Abstract: A composition comprising baicalin or a derivative thereof, more particularly in combination with chlorogenic acid or a derivative thereof, as well as the cosmetic use of such a composition and its medical applications.

Abstract: Identification of small organic molecules capable of stimulating aerobic glycolysis and cone survival would lead to the conception of new therapies of the retinal degenerative diseases. Now the inventors identified Geralexin, an acetogenin, extracted from Uvaria chamae a medicinal plant and showed that the molecule can stimulate aerobic glycolysis and cone survival. Geralexin would be suitable for the treatment of retinal degenerative diseases in particular for Age-Related Macular Degeneration (AMD) by preventing cone outer segment shortening and maintaining central vision.

Abstract: The invention relates to a jewelry item (10) comprising:—at least one cable (12) arranged to form a support mesh (14),—a plurality of decorative elements (16) threaded on said at least one cable (12) and shaped to structure the support mesh (14) according to a predetermined three-dimensional profile. The invention also relates to a jewelry assembly comprising at least two jewelry items (10) according to any one of the preceding claims and means for securing the support meshes together.

Abstract: This invention relates to compounds that are inhibitors of NGAL activity, and applications thereof.

Abstract: The present invention relates to an inhibitor of miR-671-5p for use in a method of preventing or treating fibrosis. Further, the present invention encompasses a kit comprising said inhibitor of miR-671-5p. The present invention also relates to an in vitro method for identifying a compound for preventing or treating fibrosis.

Abstract: The invention relates to a jewelry item (10) comprising:—at least one cable (12) arranged to form a support mesh (14),—a plurality of decorative elements (16) threaded on said at least one cable (12) and shaped to structure the support mesh (14) according to a predetermined three-dimensional profile. The invention also relates to a jewelry assembly comprising at least two jewelry items (10) according to any one of the preceding claims and means for securing the support meshes together.

Abstract: The present invention relates to the cosmetic or pharmaceutical use for a composition comprising a salicylic or nicotinic acid derivative inhibiting chemokines, for preventing or treating chronic internal and/or external inflammatory conditions.

Abstract: Gas supply device, comprising a frame equipped with a base and accommodating a plurality of pressurised fluid cylinders connected to a fluidic circuit comprising a first connection end connected to the cylinders and a second end comprising at least one fluidic connection intended to be connected removably to an extraction or filling element for the cylinders, the frame comprising on one of its faces at least one opening giving access to at least one connection of the circuit, the frame also comprising at least one attachment element provided to cooperate with a lifting device.

Abstract: The present invention relates to an inhibitor of miR-671-5p for use in a method of preventing or treating fibrosis. Further, the present invention encompasses a kit comprising said inhibitor of miR-671-5p. The present invention also relates to an in vitro method for identifying a compound for preventing or treating fibrosis.

Abstract: A device for supplying pressurized fluid including a pressurized fluid cylinder, at least one first tap connected to the pressurized fluid cylinder, the tap including an internal fluid circuit including an isolation valve, the device including an electronic apparatus for the wireless remote communication of data via electromagnetic waves, the electronic communication apparatus including a communication element designed to communicate wirelessly using at least one of the following frequency-modulation and/or phase-modulation low-consumption and long-range communication technologies: LoRa communication technology, communication technology from Sigfox, where the device includes a protective cap mounted on the cylinder in order to protect the first tap and a second tap connected detachably to the first tap, and the electronic communication apparatus being situated either on the cylinder, on the cap, on the first tap, or on the second tap.

Abstract: The invention relates to a device for providing pressurized fluid. The device includes a first functional assembly including a pressurized fluid bottle having an opening having attached therein a first tap including an inner fluid circuit including an insulating valve. The device includes a second functional assembly forming a physical entity separate from the first assembly. The second assembly includes a second tap having an inner fluid circuit. The first tap and the second tap include respective coupling members forming a removable rapid connection system. The device includes in the first assembly at least one electronic data storage communication unit that is removably, wirelessly queryable via electromagnetic waves and in that the second assembly includes at least one electronic communication unit for removably, wirelessly reading, via electromagnetic waves, data from the electronic member of the first assembly.

Abstract: A device for supplying pressurized fluid including a pressurized fluid cylinder, at least one first tap connected to the pressurized fluid cylinder, the tap including an internal fluid circuit including an isolation valve, the device including an electronic apparatus for the wireless remote communication of data via electromagnetic waves, the electronic communication apparatus including a communication element designed to communicate wirelessly using at least one of the following frequency-modulation and/or phase-modulation low-consumption and long-range communication technologies: LoRa communication technology, communication technology from Sigfox, where the device includes a protective cap mounted on the cylinder in order to protect the first tap and a second tap connected detachably to the first tap, and the electronic communication apparatus being situated either on the cylinder, on the cap, on the first tap, or on the second tap.

Abstract: Gas supply device, comprising a frame equipped with a base and accommodating a plurality of pressurised fluid cylinders connected to a fluidic circuit comprising a first connection end connected to the cylinders and a second end comprising at least one fluidic connection intended to be connected removably to an extraction or filling element for the cylinders, the frame comprising on one of its faces at least one opening giving access to at least one connection of the circuit, the frame also comprising at least one attachment element provided to cooperate with a lifting device.

Abstract: The present invention relates to the cosmetic or pharmaceutical use for a composition comprising a salicylic or nicotinic acid derivative inhibiting chemokines, for preventing or treating chronic internal and/or external inflammatory conditions.

Abstract: The present invention relates to the cosmetic or pharmaceutical use for a composition comprising a salicylic or nicotinic acid derivative inhibiting chemokines, for preventing or treating chronic internal and/or external inflammatory conditions.

Abstract: The invention relates to a device for providing pressurized fluid. The device includes a first functional assembly including a pressurized fluid bottle having an opening having attached therein a first tap including an inner fluid circuit including an insulating valve. The device includes a second functional assembly forming a physical entity separate from the first assembly. The second assembly includes a second tap having an inner fluid circuit. The first tap and the second tap include respective coupling members forming a removable rapid connection system. The device includes in the first assembly at least one electronic data storage communication unit that is removably, wirelessly queryable via electromagnetic waves and in that the second assembly includes at least one electronic communication unit for removably, wirelessly reading, via electromagnetic waves, data from the electronic member of the first assembly.

Abstract: The present invention concerns a compound, a salt of this compound, a derivative of this compound or a salt of this derivative, said compound being chosen among the gallic acid, its hydrolyzable polymers in gallic acid, the hexahydroxydiphenic acid, its hydrolyzable polymers in hexahydroxydiphenic acid, the ellagic acid, its hydrolyzable polymers in ellagic acid, the gallotannins, the ellagitannins, and its cosmetic applications for stimulating or repairing the barrier function of the epidermis and its pharmaceutical applications for treating lesions caused by pathologies, such as Crohn's disease.

Abstract: The invention relates to a pressure gauge comprising a dial comprising a marking and a pressure indicator configured to rotate with respect to the dial, the pressure indicator changing orientation and/or position relative to the markings as it rotates. The marking comprises a two-dimensional code that encodes at least one given information item. The pressure gauge comprises a graphic reference acting as a reference position so that the pressure indicator can be positioned in space. The invention also relates to a valve unit for distributing fluid, particularly gas, comprising such a pressure gauge and an assembly for distributing fluid, particularly gas, comprising a gas container, such as a gas cylinder, to which such a fluid distribution valve unit equipped with such a pressure gauge is fixed. Another aspect of the invention also relates to a method for measuring the pressure displayed by a pressure gauge.

Abstract: Pharmaceutical composition for treating alcohol dependence in humans comprising two active ingredients: a compound having an antagonistic action on the 5-HT2 serotoninergic receptors selected as being cyproheptadine; and a compound having an antagonistic action on the alpha1-noradrenergic receptors selected from prazosin, alfuzosin, terazosin and tamsulosin.

Abstract: Pharmaceutical composition for treating alcohol dependence in humans comprising two active ingredients: a compound having an antagonistic action on the 5-HT2 serotoninergic receptors selected as being cyproheptadine; and a compound having an antagonistic action on the alpha1-noradrenergic receptors selected from prazosin, alfuzosin, terazosin and tamsulosin.